Support for adjunctive vitamin C treatment in cancer

Mar 06, 2009

Serious flaws in a recent study, which concluded that high doses of vitamin C reduce the effectiveness of chemotherapeutic drugs in the treatment of cancer, are revealed in the current issue of Alternative and Complementary Therapies, a journal published by Mary Ann Liebert, Inc.

In the Medical Journal Watch column of the latest issue, Jack Challem, a personal nutrition coach and nutrition author from Tucson, Arizona, and a regular contributor to the Journal, challenges the findings of a study published in Cancer Research (2008;68:8031-8038), in which the authors conclude that vitamin C given to mice or cultured cells treated with common anti-cancer drugs reduces the antitumor effects of the chemotherapeutic agents.

Challem points out two main problems with the study: the oxidized form of vitamin C (dehydroascorbic acid) and not actual vitamin C (ascorbic acid) was used; and in the mouse experiments, the animals were given toxic doses of dehydroascorbic acid, a compound that is not used as a dietary supplement in humans.

"This study and the subsequent headlines [it generated] were a grievous disservice to physicians and patients with cancer," says Challem. He adds that "considerable positive research…has shown striking benefits from high-dose vitamin C (ascorbic acid) in cancer cells and animals—and in actual human beings."

High-dose intravenous vitamin C is a common form of alternative and complementary therapy for patients receiving chemotherapeutic drugs and is believed to help bring about tumor cell death. In addition, it may promote postsurgical healing by enhancing collagen formation, and increase tissue resistance to tumor spread.

Challem suggests that, "The ideal therapeutic approach would be to tailor individual treatment, including IV vitamin C, from a menu of options."

More information: The report is available free online at www.liebertpub.com/act

Source: Mary Ann Liebert

Explore further: Too few prostate cancer patients receiving active surveillance

Related Stories

The nutrition behind good sperm

Jun 25, 2015

Males with low sperm quality probably won't get much help from dining down on fish oil supplements and a bag of carrots, recent aquatic-based research suggests.

Folic acid, B vitamins do not appear to affect cancer risk

Nov 04, 2008

A daily supplementation combination that included folic acid and vitamin B6 and B12 had no significant effect on the overall risk of cancer, including breast cancer, among women at high risk of cardiovascular disease, according ...

Small RNA plays big role suppressing cancer

Apr 02, 2015

The micro RNA miR-22 has long been known for its ability to suppress cancer. However, questions remain about how it achieves this feat. For example, which molecules are regulating miR-22, and which are miR22 ...

Recommended for you

New drug for neuroblastoma shows promise in phase I study

17 hours ago

Researchers at Spectrum Health Helen DeVos Children's Hospital have completed the first clinical trial of a new treatment for children suffering from neuroblastoma. In a clinical trial led by Giselle Sholler, MD, pediatri ...

User comments : 3

Adjust slider to filter visible comments by rank

Display comments: newest first

deatopmg
2.5 / 5 (2) Mar 06, 2009
It is obvious that the not-vitamin C, vitamin C study (Cancer Research (2008;68:8031-8038)) was designed, from the beginning by the industrial medical cartel, to fail. The cartel effectively uses the media as their dupes to disseminate the phony, deceptive results and the media goes along with it because of advertising revenue.

The medical cartel and their servants, the FDA, will do everything w/in their power to limit the availability and hide the effectiveness of ANY treatment that might damage their bottom line (or in the case of ca. 75% of the FDA employees, limit the possibility of going to work in the cartel).
gopher65
1 / 5 (1) Mar 06, 2009
This guy is a nutrition coach (which requires no training). No background in the (real, non-social) sciences, no (real) research papers published (just new-agey magical-thinking garbage in fake journals), no credentials.

If someone who, you know, ISN'T A QUACK WITH A BOOK DEAL ON THE LINE comes out and bashes this study, I'll listen. Pharmaceutical companies certainly do publish fake studies from time to time for marketing purposes. But this guy doesn't count as such a person.
E_L_Earnhardt
1 / 5 (2) Mar 06, 2009
Did you ever notice that "grass" doesn't grow much in the winter! Little to sell here, but if I didn't want rapid growth of organic cells I would consider the refrigerator!

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.